Nearly three quarters of new non-cancer pain opioid prescriptions were for patients with musculoskeletal conditions, despite limited evidence of the drug’s efficacy, according to the largest U.K. study of its kind.
Nearly three quarters of new non-cancer pain opioid prescriptions were for patients with musculoskeletal conditions, despite limited evidence of the drug’s efficacy, according to the largest U.K. study of its kind.
© 2024 EarnWithSocial.ca - Canada's Technology News and Highlights | Read. Learn. Share.